![PDF) Toxicity of Concurrent Radiochemotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Systematic Review of the Literature PDF) Toxicity of Concurrent Radiochemotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Systematic Review of the Literature](https://i1.rgstatic.net/publication/237095997_Toxicity_of_Concurrent_Radiochemotherapy_for_Locally_Advanced_Non-Small-Cell_Lung_Cancer_A_Systematic_Review_of_the_Literature/links/0f31752ec20353aef1000000/largepreview.png)
PDF) Toxicity of Concurrent Radiochemotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Systematic Review of the Literature
PLOS ONE: Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data
Durvalumab Induces Sustained Survival Benefit After Concurrent Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer | Journal of Clinical Oncology
![Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2042583864/2055508616/gr1.jpg)
Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology
![Hoosier Cancer Research Network » LUN14-179 NSCLC study published in Clinical Lung Cancer, ACS journals Hoosier Cancer Research Network » LUN14-179 NSCLC study published in Clinical Lung Cancer, ACS journals](https://hoosiercancer.org/wp-content/uploads/2020/10/greg-durm.jpg)
Hoosier Cancer Research Network » LUN14-179 NSCLC study published in Clinical Lung Cancer, ACS journals
PLOS ONE: Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer
![Detection and characterization of lung cancer using cell-free DNA fragmentomes | Nature Communications Detection and characterization of lung cancer using cell-free DNA fragmentomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24994-w/MediaObjects/41467_2021_24994_Fig1_HTML.png)
Detection and characterization of lung cancer using cell-free DNA fragmentomes | Nature Communications
![PDF) Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC) PDF) Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC)](https://i1.rgstatic.net/publication/349490021_Patient-Reported_Outcomes_with_Durvalumab_With_or_Without_Tremelimumab_Versus_Standard_Chemotherapy_as_First-Line_Treatment_of_Metastatic_Non-Small_Cell_Lung_Cancer_MYSTIC/links/609887fca6fdccaebd1d787d/largepreview.png)
PDF) Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC)
![Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/af3f8eb5-b743-4c0c-8ef7-5dcd47c1abf9/gr1_lrg.jpg)
Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology
![Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3a7f842d-3d5e-45df-bb55-6ff82add44dd/gr1_lrg.jpg)
Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine
![Clinical Lung Cancer | Vol 19, Issue 6, Pages A1-A16, e815-e963, 461-544 (November 2018) | ScienceDirect.com by Elsevier Clinical Lung Cancer | Vol 19, Issue 6, Pages A1-A16, e815-e963, 461-544 (November 2018) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1525730418X00060-cov200h.gif)
Clinical Lung Cancer | Vol 19, Issue 6, Pages A1-A16, e815-e963, 461-544 (November 2018) | ScienceDirect.com by Elsevier
![Clinical Impact of High-Throughput Gene Expression Studies in Lung Cancer - Journal of Thoracic Oncology Clinical Impact of High-Throughput Gene Expression Studies in Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040021309/2053563497/gr1.jpg)